-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Overcoming Therapy Resistance in Acute Myeloid Leukemia Using Novel Epitranscriptomic Modalities

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Post-Transcriptional Mechanisms Controlling Therapy Response
Hematology Disease Topics & Pathways:
Research, Fundamental Science
Friday, December 8, 2023, 2:45 PM-3:29 PM

Konstantinos Tzelepis, PhD

University of Cambridge, Cambridge, United Kingdom

Disclosures: Tzelepis: Storm Therapeutics: Current holder of stock options in a privately-held company, Research Funding.